In many parts of the world, drug economies emerge as a consequence of deficits in development. The cultivation of plants used to make illicit drugs is just one example of this close relationship. Increasingly, international aid agencies are confronting this link and building drug policy into their development agendas.
On October 20, experienced practitioners will discuss how smart policies can address the link between drugs and development.
Speakers
- Daniel Brombacher, advisor for GIZ, the German Federal Enterprise for International Cooperation
- Eric Gutierrez, senior advisor on accountable governance for Christian Aid
- Tom Kramer, researcher for the Transnational Institute’s Drugs & Democracy Program
- Kasia Malinowska-Sempruch, director of the Open Society Global Drug Policy Program
- Ramrada Ninnad, Mae Fah Luang Foundation
Read more
Harm Reduction for All
A Lifesaving Loan: A New Investment to Help Curb the U.S. Overdose Crisis
For over a decade, the small Remedy Alliance nonprofit has revolutionized providing lifesaving healthcare for people who use drugs. Our new investment will help the group increase access to the overdose antidote naloxone.
Drug Policy
Three Decades of Drug Policy Reform Work
Over the past 30 years, Open Society has been the largest philanthropic supporter of efforts to reform drug policy and promote harm reduction around the world. This is a timeline of the Foundations’ pathbreaking work.
WAR IS OVER?
How the United States Fueled a Global Drug War, and Why It Must End
As U.S. domestic drug policy reform gains momentum, it is time the United States makes a concerted effort to de-escalate the failed war on drugs elsewhere.